Mankind Pharma Approves Closure and Winding-Up of Sri Lankan Subsidiary
Mankind Pharma Limited has announced that its Board of Directors has approved the closure and winding-up of Mankind Pharma Lanka (Private) Limited. The company stated that this action was necessary because changed regulatory requirements render the anticipated business objectives of the wholly owned subsidiary unviable.The decision to cease operations pertains to Mankind Pharma Lanka (Private) Limited, a subsidiary incorporated in Sri Lanka.
Mankind Pharma Limited confirmed that the subsidiary has maintained no business operations, and the company noted that the entity is not classified as a material subsidiary.
MANKIND Stock Price Movement
Shares of Mankind Pharma Limited are slipping by 0.01% in live trading, currently at ₹2078.7, as of 3:27 PM. The stock is seeing high volume with 636,499 shares traded, remaining within today's intraday range of ₹2014.7 to ₹2095.7.Source:
Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.